Trials / Conditions / Proton Pump Inhibitor

Proton Pump Inhibitor

14 registered clinical trials studyying Proton Pump Inhibitor — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Optimizing Medications and Lung Health in People With HIV Through Pharmacist-led Proactive E-Consults NCT07507435	Seattle Institute for Biomedical and Clinical Research	N/A
Recruiting	Potassium-Competitive Acid Blocker Versus Proton Pump Inhibitor as A Part of Bismuth Based Quadruple Therapy f NCT07165444	Tanta University	N/A
Completed	Therapeutic Effect of Vonoprazan Versus Dexlansoprazole in Treatment of Gastroesophageal Reflux Disease NCT06778395	Ayman Magd Eldin Mohammad Sadek	Phase 4
Completed	Risk Factors and Machine Learning Model for Proton Pump Inhibitor Related Acute Kidney Injury NCT05533619	Qianfoshan Hospital	—
Unknown	A RCT of the Efficacy of Vonoprazan 20mg QD in the Treatment of Helicobacter Pylori Infection NCT05590286	First People's Hospital of Hangzhou	Phase 4
Completed	Patient Journey Application for Discontinuing Inappropriate PPI Use: a Randomized Controlled Trial NCT05348252	Radboud University Medical Center	N/A
Completed	Proton Pump Inhibitors (PPI): a Study to Improve Appropriate Prescriptions in the Elderly NCT04637750	Mario Negri Institute for Pharmacological Research	N/A
Completed	Evaluation of the Long-term Tolerance of Proton Pump Inhibitor (PPI) Discontinuation in Geriatric Patients Tre NCT03980899	Fondation Hôpital Saint-Joseph	—
Withdrawn	Proton Pump Inhibitor Prevent Dual Antiplatelet Agents Induced Gastrointestinal Ulcer After Coronary Artery By NCT03038009	Ruijin Hospital	Phase 4
Completed	Evaluation of Rebound Effect After Withdrawal of Proton Pump Inhibitor in Geriatric Population NCT03467893	Fondation Hôpital Saint-Joseph	—
Completed	An Open-Label Trial of Dexlansoprazole 60mg for the Relief of Heartburn During the Fasting Month of Ramadan NCT03079050	American University of Beirut Medical Center	Phase 4
Unknown	Effects of Enteral Nutrition on Stress Ulcer Hemorrage. Multicenter Randomized Controlled Trial NCT03098537	TC Erciyes University	N/A
Completed	Sup-Icu RENal (SIREN) NCT02718261	Insel Gruppe AG, University Hospital Bern	Phase 4
Completed	On-demand PPI Therapy is Effective on Controlling Symptoms in Patients With Barrett's Esophagus. NCT04329000	Kaohsiung Veterans General Hospital.	N/A